We detected an upregulation of NEIL3 levels in higher grades in cancers such as KIRC, LGG, LIHC (liver hepatocellular carcinoma), PAAD, uterine corpus endometrial carcinoma (UCEC), and head and neck squamous cell carcinoma (HNSC) (Figure S2). Here, NEIL3 is linked to uterine corpus endometrial carcinoma.